Abingworth as of Dec. 31, 2014
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prosensa Hldgs B V Shs Usd | 33.1 | $117M | 6.2M | 18.75 | |
| Paratek Pharmaceuticals | 14.2 | $50M | 1.3M | 38.40 | |
| Sientra | 10.5 | $37M | 2.2M | 16.77 | |
| Portola Pharmaceuticals | 7.5 | $26M | 931k | 28.32 | |
| Supernus Pharmaceuticals (SUPN) | 6.8 | $24M | 2.9M | 8.31 | |
| Lombard Med (EVARF) | 6.3 | $22M | 3.5M | 6.35 | |
| Proteon Therapeutics | 5.8 | $20M | 2.0M | 10.08 | |
| Dicerna Pharmaceuticals | 5.5 | $19M | 1.2M | 16.43 | |
| Cempra | 4.8 | $17M | 714k | 23.49 | |
| Amarin Corporation (AMRN) | 2.2 | $7.8M | 8.1M | 0.97 | |
| Regulus Therapeutics | 1.5 | $5.2M | 327k | 16.03 | |
| Zogenix | 0.9 | $3.2M | 2.3M | 1.36 | |
| Hyperion Therapeutics | 0.4 | $1.5M | 63k | 23.98 | |
| OncoGenex Pharmaceuticals | 0.4 | $1.4M | 604k | 2.24 | |
| Anthera Pharmaceutcls | 0.2 | $679k | 438k | 1.55 | |
| Zalicus | 0.0 | $44k | 7.9k | 5.57 |
